Janus Henderson Group’s Benitec Biopharma BNTC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $33.8M | Sell |
2,902,794
-16,156
| -0.6% | -$188K | 0.02% | 469 |
|
2025
Q1 | $39M | Buy |
2,918,950
+302,523
| +12% | +$4.04M | 0.02% | 430 |
|
2024
Q4 | $33.3M | Buy |
2,616,427
+1,739,904
| +199% | +$22.1M | 0.02% | 476 |
|
2024
Q3 | $8.03M | Sell |
876,523
-24,293
| -3% | -$223K | ﹤0.01% | 736 |
|
2024
Q2 | $6.19M | Buy |
900,816
+656,325
| +268% | +$4.51M | ﹤0.01% | 772 |
|
2024
Q1 | $1.27M | Buy |
244,491
+64,092
| +36% | +$332K | ﹤0.01% | 1516 |
|
2023
Q4 | $589K | Sell |
180,399
-25,771
| -12% | -$84.1K | ﹤0.01% | 1912 |
|
2023
Q3 | $631K | Buy |
+206,170
| New | +$631K | ﹤0.01% | 1813 |
|